Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis-Reference-Cited by-同舟云学术

Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis

Published:2017-04-13 Issue:2 Volume:116 Page:236-243
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Lee Lawrence¹^ORCID,Alie-Cusson Fanny¹,Dubé Pierre¹,Sideris Lucas¹

Affiliation:

1. Department of Surgery, Hôpital Maisonneuve-Rosemont; Université de Montréal; Montreal Quebec Canada

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference43 articles.

1. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin;Elias;J Clin Oncol,2009

2. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis;Ahmed;J Surg Oncol,2014

3. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program;Jafari;JAMA Surg,2014

4. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms;McDonald;Int J Cancer,2009

5. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis;Cools-Lartigue;J Clin Invest,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preoperative inflammatory and nutritional markers on the prognosis of patients with peritoneal metastasis of colorectal cancer;World Journal of Gastrointestinal Oncology;2024-09-15

2. Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study;Renal Failure;2024-04-11

3. Risk factors for gastrointestinal perforation and anastomotic leak in patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC);European Journal of Surgical Oncology;2023-10

4. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment;Annals of Surgical Oncology;2023-06-02

5. Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy in Appendiceal and Colorectal Cancer: Outcomes and Survival;The American Surgeon™;2023-05-08